In Vitro Toxicology Testing Market with Manufacturing Process and CAGR Forecast by 2031 – The Bollywood Ticket


This market research report identifies Laboratory Corporation of America Holdings, Charles River Laboratories, Inc., Thermo Fisher Scientific, Eurofins Scientific, Agilent Technologies, Inc., as key vendors operating in the global in vitro toxicology testing market. This report also provides a detailed analysis of the market by toxicology criteria (systemic toxicity, cytotoxicity tests, genotoxicity tests, ocular toxicity, organic toxicity, skin toxicity, neurotoxicity and others), industry type (pharmaceutical and biopharmaceutical, cosmetic, chemical, diagnostic and food industry) and the region (North America, Europe, Asia-Pacific and Rest of the world).

Infoholic’s market research report predicts that the global in vitro toxicology testing market will grow at a CAGR of 8.2% during the forecast period 2018-2024. The In Vitro Toxicology Testing Market is Driven by Strong Opposition to Animal Testing, Rising Costs of Animal Toxicity Testing and Rising R&D Spending for Early Stage Toxicity Testing . Whereas, the lack of in vitro models and declining adoption rate is limiting the growth of the in vitro toxicology testing market to some extent.

According to the in vitro toxicology testing market analysis, Europe accounted for the largest share of the global in vitro toxicology testing market, followed by North America in 2017. The reason for this is the upsurge in investment of European Commission R&D to develop alternative methods for in vitro testing are driving demand in this region. Asia-Pacific is expected to grow at a high CAGR during the forecast period owing to the growing number of contract research organizations offering testing services, advancements in healthcare infrastructure, increased investment in the biopharmaceutical sector and rising economic conditions in the region.

Report Sample Request:

Competitive analysis and main suppliers:

There is an increase in collaborations between companies on in vitro testing of compounds. For example, in December 2016, Evotec and Celgene entered into a drug discovery collaboration for neurodegenerative diseases. Under the terms of the agreement, Celgene will use Evotec’s unique induced pluripotent stem cell (iPSC) platform that enables systematic drug screening in patient-derived disease models. In June 2017, Censo Biotechnologies Ltd. collaborated with Evotec AG to obtain and supply patient-derived induced pluripotent stem cells to support Evotec’s iPSC drug discovery platform. In addition, companies are also offering new products for in vitro testing. For example, in January 2018, STEMCELL Technologies Inc. launched two product lines for organoid research that will allow scientists to create powerful models to study human diseases in the laboratory.

Some of the Major Vendors of the In Vitro Toxicology Testing Market are:

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories, Inc.
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Agilent Technologies, Inc.

Other prominent vendors in the global in vitro toxicology testing market are Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories, Gentronix Limited, Promega Corporation, MB Research Laboratories, Evotec AG (Cyprotex plc), Catalent, Inc., Qiagen NV and niche players.

In Vitro Toxicology Testing Market by Toxicology Endpoints:

  • Systemic toxicity
  • Cytotoxicity test
  • Genotoxicity tests
  • Ocular toxicity
  • Organic toxicity
  • Cutaneous toxicity
  • Neurotoxicity
  • Others

In 2017, systemic toxicity accounted for the highest market share owing to the availability of a wide range of sub-studies, which ensure a total analysis of the toxicity and margin of safety of the tested compounds.

Place Direct Order Form @

In Vitro Toxicology Testing Market by Industry Type:

  • Pharmaceutical and biopharmaceutical industry
  • Cosmetic industry
  • Chemical industry
  • Diagnostics industry
  • Food industry

In 2017, the pharmaceutical and biopharmaceutical industry occupied a large market share and the cosmetics industry is expected to hold a high percentage during the forecast period. Increased support from regulatory authorities for the use of in vitro and in silico methods instead of animal testing to verify toxicology is driving the growth of the cosmetics industry.

Benefits of In Vitro Toxicology Testing Market:

The report provides detailed information about the services offered by In Vitro Toxicology Testing across various sectors and therapeutic regions. Through this, key stakeholders can discover key trends, drivers, investments, and initiatives of vertical players. Additionally, the report provides details about the major challenges that are going to impact the growth of the market. Moreover, the report gives comprehensive details about the business opportunities to the key stakeholders to expand their business and generate revenue in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this field before investing or expanding their business in the in vitro toxicology testing market.

Report Discount Request:


Comments are closed.